{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:40:03Z","timestamp":1789767603827,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recently, the Indian Academy of Cytologists (IAC) has published the guidelines for interpretation and reporting of serous effusions. Till date, there are no studies on its applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The present study was carried out to assess the feasibility of applying the IAC reporting categories to effusions, determine the frequency, and provide an estimate of the risk of malignancy (ROM) for individual diagnostic categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>All cases of serous effusion fluids reported in the year 2019 were retrieved from the archives and reassigned as per the IAC diagnostic categories. The clinical and histopathological follow-up information was obtained wherever possible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 1340 effusion samples were received from 1085 patients. There were 561 (51.7%) males and 524 (48.3%) females. Majority were pleural (1066, 79.5%), followed by peritoneal (187, 14%) and pericardial (87, 6.5%) effusions. The age ranged from 7 months to 92 years. There were 35 (2.6%) samples in category 1 (non-diagnostic), 954 (71.2%) in category 2 (benign), 17 (1.3%) in category 3 (atypical), 59 (4.4%) in category 4 (suspicious for malignancy) and 275 (20.5%) in category 5 (malignant). The estimated ROM in serous effusion samples was 20% for category 1, 16.7% for category 2, 50% for category 3, 94.4% for category 4 and 100% for category 5.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The categorization of serous effusion cytology samples as per the IAC diagnostic categories and as per the reporting format developed by the IAC is feasible and the management recommendations are mostly appropriate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joc.joc_224_20","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:28:00Z","timestamp":1682054880000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions"],"prefix":"10.4103","volume":"38","author":[{"given":"Reetu","family":"Kundu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshaa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Rohilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanjit","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Rajwanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240905","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4103\/0973-1482.106574","article-title":"Cytomorphological profile of neoplastic effusions: An audit of 10 years with emphasis on uncommonly encountered malignancies","volume":"8","author":"Gupta","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"R2-1-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2002\/376731","article-title":"Additional techniques in serous effusions","volume":"24","author":"Hanselaar","year":"2002","journal-title":"Anal Cell Pathol"},{"key":"R3-1-20240905","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000477556","article-title":"The Bethesda system for reporting cervical cytology: A historical perspective","volume":"61","author":"Nayar","year":"2017","journal-title":"Acta Cytol"},{"key":"R4-1-20240905","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000446270","article-title":"The Paris system for reporting urinary cytology: The quest to develop a standardized terminology","volume":"60","author":"Barkan","year":"2016","journal-title":"Acta Cytol"},{"key":"R5-1-20240905","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"R6-1-20240905","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/cncy.21898","article-title":"The Milan system for reporting salivary gland cytopathology: Analysis and suggestions of initial survey","volume":"125","author":"Rossi","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"R7-1-20240905","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cncy.21427","article-title":"Guidelines for pancreaticobiliary cytology from the Papanicolaou society of cytopathology: A review","volume":"122","author":"Pitman","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"R8-1-20240905","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dc.23457","article-title":"Standardized terminology and nomenclature for respiratory cytology: The Papanicolaou society of cytopathology guidelines","volume":"44","author":"Layfield","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"R9-1-20240905","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000501536","article-title":"Announcement: The international system for reporting serous fluid cytopathology","volume":"63","author":"Chandra","year":"2019","journal-title":"Acta Cytol"},{"key":"R10-1-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/JOC.JOC_157_19","article-title":"Indian academy of cytologists guidelines for collection, preparation, interpretation, and reporting of serous effusion fluid samples","volume":"37","author":"Srinivasan","year":"2020","journal-title":"J Cytol"},{"key":"R11-1-20240905","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7861\/clinmedicine.19-3-213","article-title":"Interpreting pleural fluid results","volume":"19","author":"Mercer","year":"2019","journal-title":"Clin Med (Lond"},{"key":"R12-1-20240905","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/dc.20133","article-title":"Malignant effusions: From diagnosis to biology","volume":"31","author":"Davidson","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"R13-1-20240905","first-page":"981","article-title":"Tuberculous pleural effusions: Advances and controversies","volume":"7","author":"Vorster","year":"2015","journal-title":"J Thorac Dis"},{"key":"R15-1-20240905","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/crj.12619","article-title":"Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions","volume":"12","author":"Froudarakis","year":"2018","journal-title":"Clin Respir J"},{"key":"R16-1-20240905","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/atm.2019.06.33","article-title":"Malignant pleural effusion and cancer of unknown primary site: A review of literature","volume":"7","author":"Awadallah","year":"2019","journal-title":"Ann Transl Med"},{"key":"R17-1-20240905","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajcp\/aqaa028","article-title":"Morphologic and immunocytochemical features of high-grade serous carcinoma of ovary in ascitic fluid effusion and fine-needle aspiration cytology","volume":"154","author":"Bansal","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"R18-1-20240905","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.5858\/arpa.2017-0444-RA","article-title":"Molecular pathology of lung cancer cytology specimens: A concise review","volume":"142","author":"Jain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R19-1-20240905","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/dc.24278","article-title":"Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature","volume":"47","author":"Farahani","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"R20-1-20240905","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jasc.2020.05.015","article-title":"The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management","volume":"9","author":"Pinto","year":"2020","journal-title":"J Am Soc Cytopathol"}],"container-title":["Journal of Cytology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JOC.JOC_224_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:02:10Z","timestamp":1787760130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JOC.JOC_224_20"}},"subtitle":["An Institutional Experience"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/joc.joc_224_20","relation":{},"ISSN":["0970-9371"],"issn-type":[{"value":"0970-9371","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}